Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business
  • interests

Trending on Bing

$1M from Wall Street
Daughter arrested
NFL preseason games
Too popular to live?
Dispute with neighbors
Receives AFI honor
Kherson bridge struck
Remains found at fort
Wants report sealed
Rainwater not potable
Tinnitus afflicts 749M
Calls out surgeon
Meteor heard out West
Comic's sudden death
Attack premeditated
Oil, gas leases paused
Joins 'Yellowjackets'
Winds destroy stage
Captain gets 18 years
Organ donation weighed
Poland deploys troops
Mayfield to start
46 satellites launched
Teen sets 100m record
Accuser to testify
Out 2-4 weeks
Snake expert bitten
Afghan women protest
Two more ships depart
Miss. to return aid
Meari soaks Japan
Italian lake going dry
New Egyptian Cabinet
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
10,600 results
BioNTech, Pfizer could deliver Omicron-adapted COVID-19 vaccines in October
BioNTech and Pfizer announced trials this month for their adapted COVID-19 vaccines, to fight faster-spreading Omicron ...
UPI.com on MSN.com
5d
Vaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech Announce Trials
BioNTech and its U.S. partner Pfizer have already begun manufacturing Covid-19 boosters that are adapted for multiple Omicron ...
Forbes on MSN.com
5d
COVID-19 vaccine maker BioNTech expects updated omicron-specific shots by October
BioNTech, with its partner Pfizer, expects to begin deliveries of two omicron-adapted vaccines as soon as October in time for ...
Washington Examiner on MSN.com
5d
Pfizer, BioNTech to study 'bivalent' booster as FDA weighs approach
The small-scale study is part of the companies’ efforts to update their vaccine in time for a potential fall vaccination ...
BioPharma Dive
17d
U.S. to Offer Updated COVID Booster Shots in September
The Biden administration plans to begin a COVID-19 booster campaign with reformulated vaccines in September. The new boosters ...
WebMD
10d
Moderna and Pfizer to start clinical trials for COVID-19 boosters that target BA.5 ‘in the near future’
4/5-containing vaccine it’s developing with BioNTech BNTX ... He told investors that Pfizer and the FDA have agreed that the application for the updated booster will include “safety and ...
MarketWatch15d
UPDATE 2-BioNTech expects Omicron-adapted vaccine deliveries as soon as October
BioNTech expects to begin deliveries of two Omicron-adapted vaccines as soon as October, which will help spur demand in the fourth quarter, the German biotech firm said on Monday as it reaffirmed its ...
YAHOO!Finance
5d
BioNTech Announces Second Quarter Financial Results and Corporate Update
Second quarter revenues of EUR3.2 billion1, net profit of EUR1.7 billion and fully diluted earnings per share of EUR6.45 ($6.872) as well as first half ...
MarketWatch
5d
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation ...
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a randomized, active-controlled, observer-blind Phase ...
The Bakersfield Californian
17d
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
NEW YORK and MAINZ, Germany, July 27, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a randomized, active-controlled, observer-blind ...
Yahoo Finance17d
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
NEW YORK and MAINZ, Germany, July 27, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a randomized, active-controlled, observer ...
Yahoo Sport Australia17d
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
NEW YORK and MAINZ, Germany, July 27, 2022 — Pfizer Inc. (NYSE ... kinds of immunocompromise a single booster dose to individuals 5 through 11 years of age who have completed a primary series with ...
Yahoo Finance17d
© 2022 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback